12.01.06
NIH Study to Evaluate Effect of Antioxidants & Fish Oil on Progression of AMD
The National Institutes of Health (NIH), Bethesda, MD, has announced a nationwide study to see if a modified combination of vitamins, minerals and fish oil can further slow the progression of vision loss from age-related macular degeneration (AMD). This new study, called the Age-Related Eye Disease Study 2 (AREDS2), will build upon results from the earlier Age-Related Eye Disease Study (AREDS). Results of the original study were released five years ago and found that high-dose antioxidant vitamins and minerals (vitamins C and E, beta-carotene, zinc and copper) taken by mouth reduced the risk of progression to advanced AMD by 25%, and the risk of moderate vision loss by 19%. AREDS2 will refine the findings of the original study by adding lutein and zeaxanthin and the omega 3 fatty acids DHA and EPA (derived from fish and vegetable oils) to the study formulation.
DSM Nutritional Products, Inc., Parsippany, NJ, will provide the lutein, zeaxanthin and omega 3 fatty acids to be used in the study, which will determine if this new modified combination of ingredients can further slow the progression of vision loss from AMD.
The National Institutes of Health (NIH), Bethesda, MD, has announced a nationwide study to see if a modified combination of vitamins, minerals and fish oil can further slow the progression of vision loss from age-related macular degeneration (AMD). This new study, called the Age-Related Eye Disease Study 2 (AREDS2), will build upon results from the earlier Age-Related Eye Disease Study (AREDS). Results of the original study were released five years ago and found that high-dose antioxidant vitamins and minerals (vitamins C and E, beta-carotene, zinc and copper) taken by mouth reduced the risk of progression to advanced AMD by 25%, and the risk of moderate vision loss by 19%. AREDS2 will refine the findings of the original study by adding lutein and zeaxanthin and the omega 3 fatty acids DHA and EPA (derived from fish and vegetable oils) to the study formulation.
DSM Nutritional Products, Inc., Parsippany, NJ, will provide the lutein, zeaxanthin and omega 3 fatty acids to be used in the study, which will determine if this new modified combination of ingredients can further slow the progression of vision loss from AMD.